Lorlatinib Impurity 25 | CAS 1454847-99-4 - Request Quote
Lorlatinib Impurity 25
| SZ CAT No: | SZ-L054033 |
| CAS No | 1454847-99-4 |
| Mol.F. | C15H15FN2O3 |
| Mol.Wt. | 290.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lorlatinib Impurity 25 is chemically Methyl (R)-2-(1-((2-aminopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate. Lorlatinib Impurity 25 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib Impurity 25 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1454847-99-4
Purchase 1454847-99-4
Order 1454847-99-4
Enquire 1454847-99-4
price of 1454847-99-4
1454847-99-4 Supplier
1454847-99-4 Manufacturer
1454847-99-4 Exporter
buy high quality Lorlatinib Impurity 25
Purchase Lorlatinib Impurity 25
Lorlatinib Impurity 25 suppliers
Lorlatinib Impurity 25 manufacturers
Lorlatinib Impurity 25 price
Order Lorlatinib Impurity 25
Enquire Lorlatinib Impurity 25
Lorlatinib Impurity 25 cost
Lorlatinib Impurity 25 Supplier
Lorlatinib Impurity 25 Distributor
Lorlatinib Impurity 25 for Method Validation
Lorlatinib Reference Standard
Lorlatinib Impurity 25 for ANDA Filing
Lorlatinib Impurity 25 for Forced Degradation Studies
Lorlatinib Impurity 25 Identification Standards
Lorlatinib Impurity 25 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.